Brian Lian - Mar 30, 2023 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role: President & CEO, Director
Signature: /s/ Michael Morneau, as Attorney-in-Fact
Stock symbol: VKTX
Transactions as of: Mar 30, 2023
Transactions value $: -$6,752,419
Form type: 4
Date filed: 4/3/2023, 07:26 PM
Previous filing: Jan 5, 2023
Next filing: Apr 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VKTX	Common Stock, par value $0.00001 per share	Options Exercise	$142K	+116K	+5.1%	$1.23^*	2.39M	Mar 30, 2023	Direct	F1
transaction	VKTX	Common Stock, par value $0.00001 per share	Options Exercise	$185K	+19.5K	+0.82%	$9.49	2.41M	Mar 30, 2023	Direct	F1
transaction	VKTX	Common Stock, par value $0.00001 per share	Sale	-$1.49M	-88K	-3.65%	$16.95	2.32M	Mar 30, 2023	Direct	F1
transaction	VKTX	Common Stock, par value $0.00001 per share	Sale	-$1.14M	-65.4K	-2.82%	$17.45	2.25M	Mar 30, 2023	Direct	F1
transaction	VKTX	Common Stock, par value $0.00001 per share	Options Exercise	$645K	+68K	+3.01%	$9.49	2.32M	Mar 31, 2023	Direct	F1
transaction	VKTX	Common Stock, par value $0.00001 per share	Sale	-$1.19M	-68K	-2.93%	$17.45	2.25M	Mar 31, 2023	Direct	F1
transaction	VKTX	Common Stock, par value $0.00001 per share	Sale	-$393K	-22K	-0.98%	$17.85	2.23M	Apr 3, 2023	Direct	F1
transaction	VKTX	Common Stock, par value $0.00001 per share	Award	$0	+300K	+13.44%	$0.00	2.53M	Apr 3, 2023	Direct	F2
transaction	VKTX	Common Stock, par value $0.00001 per share	Tax liability	-$3.51M	-200K	-7.9%	$17.57	2.33M	Apr 3, 2023	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VKTX	Stock Option (Right to Buy)	Options Exercise	$0	-116K	-46.34%	$0.00	134K	Mar 30, 2023	Common Stock	116K	$1.23	Direct	F1, F4
transaction	VKTX	Stock Option (Right to Buy)	Options Exercise	$0	-19.5K	-22.32%	$0.00	68K	Mar 30, 2023	Common Stock	19.5K	$9.49	Direct	F1, F5
transaction	VKTX	Stock Option (Right to Buy)	Options Exercise	$0	-68K	-100%	$0.00^*	0	Mar 31, 2023	Common Stock	68K	$9.49	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person
F2	The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2022, 66.67% of which vested on April 3, 2023 upon the achievement of two non-financial performance goals.
F3	These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units.
F4	25% of the shares subject to the option vested on each one year anniversary of the grant date.
F5	25% of the shares subject to the option vested upon grant and 25% of the shares subject to the option vested on each one year anniversary of the grant date.